ELMD
Electromed, Inc.
Price Chart
Latest Quote
$38.68
+1.54 (+4.15%)
Current Price
| Previous Close | $37.14 |
| Open | $37.25 |
| Day High | $38.82 |
| Day Low | $35.61 |
| Volume | 42,848 |
Stock Information
| Shares Outstanding | 8.28M |
| Total Debt | $81K |
| Cash Equivalents | $16.98M |
| Revenue | $71.75M |
| Net Income | $10.10M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $320.27M |
| P/E Ratio | 33.06 |
| EPS (TTM) | $1.17 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $303.37M |
| Sales | $71.75M |
| Income | $10.10M |
| Book/sh | $5.94 |
| Cash/sh | $2.05 |
| Employees | 177 |
Financial Ratios
| Quick Ratio | 4.53 |
| Current Ratio | 4.91 |
| Debt/Eq | 0.17 |
| EPS Growth TTM | 58.80% |
Returns & Margins
| ROA | 14.86% |
| ROE | 21.70% |
| Gross Margin | 78.44% |
| Operating Margin | 20.28% |
| Profit Margin | 14.08% |
Ownership
| Insider Ownership | 21.44% |
| Institutional Ownership | 59.10% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 63.41 |
| PEG | 0.35 |
| P/S | 4.46 |
| P/B | 6.51 |
Analyst Data
| Recommendation | none |
| Target Price | $40.33 |
Technical Indicators
| SMA20 | $37.49 |
| SMA50 | $31.74 |
| SMA200 | $27.31 |
| RSI | 54.97 |
| ATR | 2.0771 |
| Shares Float | 6.48M |
| Short Float | 2.04% |
| Short Ratio | 2.15 |
| Volatility | 0.52 |
| Rel Volume | 1.06 |
Performance History
| Week | +2.84% |
| Month | +0.81% |
| Quarter | +64.67% |
| 6 Months | +29.45% |
| YTD | +41.22% |
| Year | +92.73% |
| 3 Years | +234.89% |
| 5 Years | +256.17% |
| 10 Years | +889.26% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $38.68 | 64,600 |
| 2026-06-17 | $37.14 | 57,000 |
| 2026-06-16 | $37.55 | 55,200 |
| 2026-06-15 | $37.44 | 67,600 |
| 2026-06-12 | $37.14 | 39,500 |
| 2026-06-11 | $37.61 | 66,600 |
| 2026-06-10 | $37.18 | 45,400 |
| 2026-06-09 | $36.29 | 48,900 |
| 2026-06-08 | $37.08 | 58,600 |
| 2026-06-05 | $37.69 | 55,400 |
| 2026-06-04 | $36.72 | 79,400 |
| 2026-06-03 | $35.65 | 45,400 |
| 2026-06-02 | $36.58 | 62,000 |
| 2026-06-01 | $36.63 | 55,500 |
| 2026-05-29 | $37.72 | 68,500 |
| 2026-05-28 | $39.29 | 54,300 |
| 2026-05-27 | $38.26 | 52,500 |
| 2026-05-26 | $38.30 | 96,800 |
| 2026-05-22 | $38.22 | 63,300 |
| 2026-05-21 | $38.58 | 86,100 |
| 2026-05-20 | $37.74 | 59,000 |
| 2026-05-19 | $38.37 | 68,500 |
About Electromed, Inc.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
đ° Latest News
Here's Why Momentum in Electromed (ELMD) Should Keep going
Zacks âĸ 2026-06-19T12:55:02Z
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks âĸ 2026-06-03T16:45:03Z
Best Momentum Stocks to Buy for June 2nd
Zacks âĸ 2026-06-02T14:00:00Z
New Strong Buy Stocks for June 2nd
Zacks âĸ 2026-06-02T10:13:00Z
Electromed, Inc. (ELMD) Hits Fresh High: Is There Still Room to Run?
Zacks âĸ 2026-06-01T13:15:02Z
Here's What Could Help Electromed (ELMD) Maintain Its Recent Price Strength
Zacks âĸ 2026-06-01T12:55:02Z
Teladoc Health Broadens Virtual Care Reach Through Walmart Platform
Zacks âĸ 2026-05-29T14:57:00Z
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical
Zacks âĸ 2026-05-22T13:27:00Z
3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes
Zacks âĸ 2026-05-21T17:31:00Z
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
Zacks âĸ 2026-05-21T13:40:03Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $14,029,000 | $12,990,000 | $11,548,000 | $10,217,000 |
| Cost Of Revenue | $14,029,000 | $12,990,000 | $11,548,000 | $10,217,000 |
| Total Revenue | $64,000,000 | $54,716,000 | $48,067,000 | $41,659,000 |
| Operating Revenue | $64,000,000 | $54,716,000 | $48,067,000 | $41,659,000 |
| Expenses | ||||
| Total Expenses | $54,340,000 | $48,135,000 | $44,059,000 | $38,687,000 |
| Net Non Operating Interest Income Expense | $624,000 | $455,000 | $78,000 | $25,000 |
| Operating Expense | $40,311,000 | $35,145,000 | $32,511,000 | $28,470,000 |
| Other Income Expense | - | - | - | - |
| Other Non Operating Income Expenses | - | - | - | - |
| Total Other Finance Cost | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Net Interest Income | $624,000 | $455,000 | $78,000 | $25,000 |
| Interest Income | $624,000 | $455,000 | $78,000 | $25,000 |
| Normalized Income | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Net Income From Continuing And Discontinued Operation | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Total Operating Income As Reported | $9,660,000 | $6,581,000 | $4,008,000 | $2,972,000 |
| Net Income Common Stockholders | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Net Income | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Net Income Including Noncontrolling Interests | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Net Income Continuous Operations | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Pretax Income | $10,284,000 | $7,036,000 | $4,086,000 | $2,997,000 |
| Interest Income Non Operating | $624,000 | $455,000 | $78,000 | $25,000 |
| Operating Income | $9,660,000 | $6,581,000 | $4,008,000 | $2,972,000 |
| Gross Profit | $49,971,000 | $41,726,000 | $36,519,000 | $31,442,000 |
| Per Share | ||||
| Diluted EPS | $0.85 | $0.58 | $0.36 | $0.26 |
| Basic EPS | $0.89 | $0.60 | $0.37 | $0.27 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $10,832,000 | $7,422,000 | $4,621,000 | $3,600,000 |
| Reconciled Depreciation | $1,172,000 | $841,000 | $613,000 | $628,000 |
| EBITDA (Bullshit earnings) | $10,832,000 | $7,422,000 | $4,621,000 | $3,600,000 |
| EBIT | $9,660,000 | $6,581,000 | $4,008,000 | $2,972,000 |
| Diluted Average Shares | $8,914,421 | $8,864,585 | $8,700,833 | $8,768,703 |
| Basic Average Shares | $8,454,100 | $8,562,245 | $8,463,684 | $8,471,320 |
| Diluted NI Availto Com Stockholders | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Tax Provision | $2,747,000 | $1,886,000 | $920,000 | $692,000 |
| Research And Development | $996,000 | $656,000 | $916,000 | $1,356,000 |
| Selling General And Administration | $39,315,000 | $34,489,000 | $31,595,000 | $27,114,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $41,886,000 | $43,888,000 | $37,062,000 | $33,574,000 |
| Total Assets | $53,802,000 | $52,234,000 | $45,806,000 | $41,364,000 |
| Total Non Current Assets | $8,720,000 | $8,061,000 | $8,019,000 | $6,825,000 |
| Other Non Current Assets | $23,000 | - | - | - |
| Non Current Deferred Assets | $2,462,000 | $2,152,000 | $1,581,000 | $1,538,000 |
| Non Current Deferred Taxes Assets | $2,462,000 | $2,152,000 | $1,581,000 | $1,538,000 |
| Goodwill And Other Intangible Assets | $1,323,000 | $657,000 | $605,000 | $599,000 |
| Other Intangible Assets | $1,323,000 | $657,000 | $605,000 | $599,000 |
| Current Assets | $45,082,000 | $44,173,000 | $37,787,000 | $34,539,000 |
| Other Current Assets | $392,000 | $329,000 | $1,577,000 | $1,870,000 |
| Inventory | $3,299,000 | $3,712,000 | $4,221,000 | $3,178,000 |
| Receivables | $26,104,000 | $24,052,000 | $24,617,000 | $21,338,000 |
| Other Receivables | $1,036,000 | $719,000 | $487,000 | $286,000 |
| Taxes Receivable | $408,000 | $0 | - | - |
| Accounts Receivable | $24,660,000 | $23,333,000 | $24,130,000 | $21,052,000 |
| Allowance For Doubtful Accounts Receivable | $-45,000 | $-45,000 | $-45,000 | $-45,000 |
| Gross Accounts Receivable | $24,705,000 | $23,378,000 | $24,175,000 | $21,097,000 |
| Cash Cash Equivalents And Short Term Investments | $15,287,000 | $16,080,000 | $7,372,000 | $8,153,000 |
| Cash And Cash Equivalents | $15,287,000 | $16,080,000 | $7,372,000 | $8,153,000 |
| Prepaid Assets | - | - | - | $1,870,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $10,593,000 | $7,689,000 | $8,139,000 | $7,191,000 |
| Total Non Current Liabilities Net Minority Interest | $125,000 | $12,000 | $86,000 | $41,000 |
| Other Non Current Liabilities | $125,000 | $12,000 | $86,000 | $41,000 |
| Current Liabilities | $10,468,000 | $7,677,000 | $8,053,000 | $7,150,000 |
| Payables And Accrued Expenses | $3,744,000 | $2,217,000 | $3,657,000 | $3,152,000 |
| Payables | $2,667,000 | $1,287,000 | $1,708,000 | $1,312,000 |
| Total Tax Payable | $0 | $277,000 | $336,000 | $51,000 |
| Income Tax Payable | $0 | $277,000 | $336,000 | $51,000 |
| Accounts Payable | $2,667,000 | $1,010,000 | $1,372,000 | $1,261,000 |
| Other Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $43,209,000 | $44,545,000 | $37,667,000 | $34,173,000 |
| Total Equity Gross Minority Interest | $43,209,000 | $44,545,000 | $37,667,000 | $34,173,000 |
| Stockholders Equity | $43,209,000 | $44,545,000 | $37,667,000 | $34,173,000 |
| Retained Earnings | $21,185,000 | $23,668,000 | $18,793,000 | $15,780,000 |
| Other | ||||
| Ordinary Shares Number | $8,349,176 | $8,637,883 | $8,555,238 | $8,475,438 |
| Share Issued | $8,349,176 | $8,637,883 | $8,555,238 | $8,475,438 |
| Tangible Book Value | $41,886,000 | $43,888,000 | $37,062,000 | $33,574,000 |
| Invested Capital | $43,209,000 | $44,545,000 | $37,667,000 | $34,173,000 |
| Working Capital | $34,614,000 | $36,496,000 | $29,734,000 | $27,389,000 |
| Total Capitalization | $43,209,000 | $44,545,000 | $37,667,000 | $34,173,000 |
| Additional Paid In Capital | $21,941,000 | $20,790,000 | $18,788,000 | $18,308,000 |
| Capital Stock | $83,000 | $87,000 | $86,000 | $85,000 |
| Common Stock | $83,000 | $87,000 | $86,000 | $85,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,079,000 | $3,893,000 | $3,018,000 | $2,742,000 |
| Current Provisions | $1,645,000 | $1,567,000 | $1,378,000 | $1,256,000 |
| Current Accrued Expenses | $1,077,000 | $930,000 | $1,949,000 | $1,840,000 |
| Net PPE | $4,912,000 | $5,252,000 | $5,833,000 | $4,688,000 |
| Accumulated Depreciation | $-6,004,000 | $-5,170,000 | $-4,416,000 | $-3,959,000 |
| Gross PPE | $10,916,000 | $10,422,000 | $10,249,000 | $8,647,000 |
| Construction In Progress | $224,000 | $72,000 | $8,000 | $957,000 |
| Other Properties | $4,626,000 | $4,293,000 | $4,275,000 | $3,512,000 |
| Machinery Furniture Equipment | $2,236,000 | $2,236,000 | $2,166,000 | $396,000 |
| Buildings And Improvements | $3,457,000 | $3,448,000 | $3,427,000 | $3,420,000 |
| Land And Improvements | $373,000 | $373,000 | $373,000 | $362,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-277,000 | $-397,000 | $-257,000 | $-291,000 |
| Other Inventories | $393,000 | $265,000 | $265,000 | $228,000 |
| Finished Goods | $928,000 | $834,000 | $323,000 | $469,000 |
| Work In Process | $180,000 | $454,000 | $470,000 | $100,000 |
| Raw Materials | $2,075,000 | $2,556,000 | $3,420,000 | $2,672,000 |
| Treasury Shares Number | - | $18,361 | - | - |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $11,087,000 | $8,672,000 | $-401,000 | $-2,211,000 |
| Operating Activities | ||||
| Operating Cash Flow | $11,393,000 | $9,067,000 | $1,315,000 | $-686,000 |
| Cash Flow From Continuing Operating Activities | $11,393,000 | $9,067,000 | $1,315,000 | $-686,000 |
| Investing Activities | ||||
| Capital Expenditure | $-306,000 | $-395,000 | $-1,716,000 | $-1,525,000 |
| Investing Cash Flow | $-306,000 | $-395,000 | $-1,716,000 | $-1,525,000 |
| Cash Flow From Continuing Investing Activities | $-306,000 | $-395,000 | $-1,716,000 | $-1,525,000 |
| Capital Expenditure Reported | $-306,000 | $-395,000 | $-1,716,000 | $-1,525,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-10,000,000 | $-275,000 | $-153,000 | $-1,448,000 |
| Financing Cash Flow | $-11,880,000 | $36,000 | $-380,000 | $-1,525,000 |
| Cash Flow From Continuing Financing Activities | $-11,880,000 | $36,000 | $-380,000 | $-1,525,000 |
| Net Other Financing Charges | $-2,278,000 | - | $-310,000 | $-77,000 |
| Net Common Stock Issuance | $-10,000,000 | $-275,000 | $-153,000 | $-1,448,000 |
| Other | ||||
| Income Tax Paid Supplemental Data | $3,742,000 | $2,514,000 | $676,000 | $1,418,000 |
| End Cash Position | $15,287,000 | $16,080,000 | $7,372,000 | $8,153,000 |
| Beginning Cash Position | $16,080,000 | $7,372,000 | $8,153,000 | $11,889,000 |
| Changes In Cash | $-793,000 | $8,708,000 | $-781,000 | $-3,736,000 |
| Proceeds From Stock Option Exercised | $398,000 | $311,000 | $83,000 | $0 |
| Common Stock Payments | $-10,000,000 | $-275,000 | $-153,000 | $-1,448,000 |
| Change In Working Capital | $-277,000 | $1,955,000 | $-3,129,000 | $-4,106,000 |
| Change In Payables And Accrued Expense | $2,151,000 | $-390,000 | $981,000 | $2,201,000 |
| Change In Accrued Expense | $1,186,000 | $875,000 | $276,000 | $268,000 |
| Change In Payable | $965,000 | $-1,265,000 | $705,000 | $1,933,000 |
| Change In Account Payable | $1,650,000 | $-1,206,000 | $420,000 | $2,170,000 |
| Change In Tax Payable | $-685,000 | $-59,000 | $285,000 | $-237,000 |
| Change In Income Tax Payable | $-685,000 | $-59,000 | $285,000 | $-237,000 |
| Change In Prepaid Assets | $-959,000 | $1,321,000 | $202,000 | $-1,322,000 |
| Change In Inventory | $175,000 | $459,000 | $-1,033,000 | $-1,072,000 |
| Change In Receivables | $-1,644,000 | $565,000 | $-3,279,000 | $-3,913,000 |
| Changes In Account Receivables | $-1,327,000 | $797,000 | $-3,078,000 | $-4,020,000 |
| Stock Based Compensation | $3,059,000 | $1,692,000 | $708,000 | $976,000 |
| Asset Impairment Charge | $212,000 | $0 | - | - |
| Deferred Tax | $-310,000 | $-571,000 | $-43,000 | $-489,000 |
| Deferred Income Tax | $-310,000 | $-571,000 | $-43,000 | $-489,000 |
| Depreciation Amortization Depletion | $1,172,000 | $841,000 | $613,000 | $628,000 |
| Depreciation And Amortization | $1,172,000 | $841,000 | $613,000 | $628,000 |
| Amortization Cash Flow | $133,000 | $52,000 | $63,000 | $125,000 |
| Amortization Of Intangibles | $133,000 | $52,000 | $63,000 | $125,000 |
| Depreciation | $1,039,000 | $789,000 | $550,000 | $503,000 |
| Net Income From Continuing Operations | $7,537,000 | $5,150,000 | $3,166,000 | $2,305,000 |
| Change In Other Working Capital | - | $875,000 | $276,000 | $268,000 |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
| Net PPE Purchase And Sale | - | - | - | - |
| Purchase Of PPE | - | - | - | - |
Fetched: 2026-06-20